These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33102398)
1. Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option. Argentiero A; Calabrese A; Sciacovelli AM; Delcuratolo S; Solimando AG; Brunetti O Can J Gastroenterol Hepatol; 2020; 2020():8679751. PubMed ID: 33102398 [TBL] [Abstract][Full Text] [Related]
2. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile? Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113 [TBL] [Abstract][Full Text] [Related]
3. A case of metachronous oligo-hepatic and peritoneal metastases of pancreatic cancer with a favorable outcome after conversion surgery combined with perioperative sequential chemotherapy. Tohyama T; Tanno Y; Murakami T; Hayashi T; Fujimoto Y; Takehara K; Seshimo K; Fukuhara R; Omori M; Matsumoto T Clin J Gastroenterol; 2024 Apr; 17(2):371-381. PubMed ID: 38291249 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1). Wei M; Shi S; Hua J; Xu J; Yu X; BMJ Open; 2019 Dec; 9(12):e033452. PubMed ID: 31818843 [TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability. Shi HJ; Jin C; Fu DL World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110 [TBL] [Abstract][Full Text] [Related]
6. A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy. Crippa S; Cirocchi R; Weiss MJ; Partelli S; Reni M; Wolfgang CL; Hackert T; Falconi M Updates Surg; 2020 Mar; 72(1):39-45. PubMed ID: 31997233 [TBL] [Abstract][Full Text] [Related]
8. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX. Ozaki K; Hayashi H; Ikuta Y; Masuda T; Akaboshi S; Ogata K; Matumoto K; Ogawa K; Kamio T; Baba H; Takamori H Clin J Gastroenterol; 2019 Dec; 12(6):603-608. PubMed ID: 30993652 [TBL] [Abstract][Full Text] [Related]
9. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis. Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW; Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732 [TBL] [Abstract][Full Text] [Related]
10. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report. Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391 [TBL] [Abstract][Full Text] [Related]
11. [Laparoscopic Liver Resection for Liver Metastasis from Unresectable Pancreatic Ductal Adenocarcinoma Well-Controlled by Chemotherapy-A Case Report]. Nobori C; Tsukamoto T; Nishiyama T; Kunimoto T; Kaizaki R; Inoue T; Nishiguchi Y Gan To Kagaku Ryoho; 2020 Dec; 47(13):1881-1883. PubMed ID: 33468860 [TBL] [Abstract][Full Text] [Related]
12. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas. Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355 [TBL] [Abstract][Full Text] [Related]
13. [Pancreatic Cancer with Liver Metastasis Treated with Radical Surgery after Chemotherapy]. Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Inatome J; Naito A; Murakami K; Kagawa Y; Takeno A; Egawa C; Kato T; Tamura S Gan To Kagaku Ryoho; 2016 Nov; 43(12):1975-1977. PubMed ID: 28133194 [TBL] [Abstract][Full Text] [Related]
14. Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma. Reni M; Peretti U; Zanon S; Macchini M; Balzano G; Mazza E; Tamburrino D; Orsi G; Arcidiacono PG; Falconi M; Gianni L Cancer Chemother Pharmacol; 2020 Apr; 85(4):641-650. PubMed ID: 32157412 [TBL] [Abstract][Full Text] [Related]
15. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? Frigerio I; Regi P; Giardino A; Scopelliti F; Girelli R; Bassi C; Gobbo S; Martini PT; Capelli P; D'Onofrio M; Malleo G; Maggino L; Viviani E; Butturini G Ann Surg Oncol; 2017 Aug; 24(8):2397-2403. PubMed ID: 28516291 [TBL] [Abstract][Full Text] [Related]
16. Searching for novel multimodal treatments in oligometastatic pancreatic cancer. Filippini DM; Grassi E; Palloni A; Carloni R; Casadei R; Ricci C; Serra C; Ercolani G; Brandi G; Di Marco M BMC Cancer; 2020 Mar; 20(1):271. PubMed ID: 32228504 [TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis by site of primary tumor of patients with unresectable locally-advanced or metastatic pancreatic adenocarcinoma receiving chemotherapy. Colloca GA; Venturino A; Guarneri D Clin Exp Metastasis; 2019 Dec; 36(6):519-525. PubMed ID: 31578654 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study. Decoster C; Gilabert M; Autret A; Turrini O; Oziel-Taieb S; Poizat F; Giovannini M; Viens P; Iovanna J; Raoul JL Oncotarget; 2016 Jul; 7(29):45649-45655. PubMed ID: 27286454 [TBL] [Abstract][Full Text] [Related]
19. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future. Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269 [TBL] [Abstract][Full Text] [Related]
20. Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma. Akahori T; Sho M; Yanagimoto H; Satoi S; Nagai M; Nishiwada S; Nakagawa K; Nakamura K; Yamamoto T; Hirooka S; Yamaki S; Ikeda N Oncologist; 2019 Jun; 24(6):749-e224. PubMed ID: 30679316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]